SCHEMBL9833735

SCHEMBL9833735

Cc1ccc(S(=O)(=O)NCC2CCCC(=O)C2)cc1

nearest known ligand 0.55

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 6/20 0.55
ALDH1A1 P00352 6/20 0.55
MEN1 O00255 4/20 0.55
CYP2C9 P11712 1/20 0.55
SLC12A2 P55011 1/20 0.50
SLC12A5 Q9H2X9 1/20 0.50
LMNA P02545 1/20 0.47
GBA1 P04062 1/20 0.47
L3MBTL1 Q9Y468 2/20 0.45
MAPT P10636 1/20 0.45
CYP3A4 P08684 2/20 0.44
ATM Q13315 2/20 0.44
CA12 O43570 1/20 0.44
CYP1A2 P05177 1/20 0.44
CA9 Q16790 1/20 0.44
TSHR P16473 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9833285 0.92 ALDH1A1 (0.58) KMT2AALDH1A1MEN1CYP2C9SLC12A2
SCHEMBL9834257 0.86 SMN1; SMN2 (0.50) KMT2AALDH1A1MEN1LMNAGBA1
SCHEMBL9832410 0.86 CNR1 (0.48) KMT2AALDH1A1MEN1LMNAGBA1
SCHEMBL9834810 0.86 GBA1 (0.65) KMT2AALDH1A1MEN1GBA1
SCHEMBL7699722 0.83 KMT2A (0.68) KMT2AALDH1A1MEN1CYP2C9SLC12A2
SCHEMBL9831878 0.78 TBXA2R (0.51) KMT2AALDH1A1MEN1LMNAGBA1
SCHEMBL9833087 0.78 CNR1 (0.50) KMT2AALDH1A1MEN1GBA1CA9
SCHEMBL30025907 0.77 NPY1R (0.63) KMT2AALDH1A1MEN1CYP2C9SLC12A2
SCHEMBL27163604 0.77 NPY1R (0.63) KMT2AALDH1A1MEN1CYP2C9SLC12A2
SCHEMBL9834420 0.77 GBA1 (0.69) KMT2AALDH1A1MEN1GBA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0242518-B1 Cycloalkano[1,2-b]indole-sulfonamides BAYER AG (DE) 1991-04-10 EP disclosed
US-4988820-A Inhibiting platelet aggregation, anticoagulants, thromboxane a2 antagonist BAYER AKTIENGESELLSCHAFT (DE) 1991-01-29 US disclosed
US-4965258-A Anticoagulant; thromboxane a2 antagonist BAYER AKTIENGESELLSCHAFT (DE) 1990-10-23 US disclosed
US-4904797-A REACTING A (BENZENESULFONAMIDOALKYL)CYCLOALKANO(1,2-B)INDOLE WITH ACRYLONITRILE; HYDROLYSIS, HYDROGENATION, REDUCTION BAYER AKTIENGESELLSCHAFT (DE) 1990-02-27 US disclosed
US-4827032-A INTERMEDIATES FOR ANTICOAGULANTS BAYER AKTIENGESELLSCHAFT (DE) 1989-05-02 US disclosed
EP-0242518-A1 Cycloalkano[1,2-b]indole-sulfonamides BAYER AG (DE) 1987-10-28 EP disclosed